NO116545B - - Google Patents

Download PDF

Info

Publication number
NO116545B
NO116545B NO149593A NO14959360A NO116545B NO 116545 B NO116545 B NO 116545B NO 149593 A NO149593 A NO 149593A NO 14959360 A NO14959360 A NO 14959360A NO 116545 B NO116545 B NO 116545B
Authority
NO
Norway
Prior art keywords
lower alkyl
amino
mercapto
halogen
acid
Prior art date
Application number
NO149593A
Other languages
English (en)
Norwegian (no)
Inventor
T Shen
L Sarett
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO116545B publication Critical patent/NO116545B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO149593A 1959-09-03 1960-09-02 NO116545B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83777459A 1959-09-03 1959-09-03

Publications (1)

Publication Number Publication Date
NO116545B true NO116545B (fr) 1969-04-14

Family

ID=25275378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO149593A NO116545B (fr) 1959-09-03 1960-09-02

Country Status (5)

Country Link
BE (1) BE594596A (fr)
CH (1) CH415631A (fr)
ES (1) ES260797A1 (fr)
GB (1) GB948460A (fr)
NO (1) NO116545B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB957990A (en) * 1961-03-14 1964-05-13 Merck & Co Inc Salts of substituted indoles
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs

Also Published As

Publication number Publication date
BE594596A (fr) 1961-02-28
CH415631A (de) 1966-06-30
ES260797A1 (es) 1961-04-01
GB948460A (en) 1964-02-05

Similar Documents

Publication Publication Date Title
DE4338770A1 (de) Indol-2-alkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
DE3018545A1 (de) 2- eckige klammer auf mercapto-1- oxo(nieder-alkyl) eckige klammer zu -1,2,3,4-tetrahydroisochinolin-3- carbonsaeuren
EP0217372B1 (fr) Dérivés de labdane polyoxygénés, leur procédé de préparation et leur utilisation comme médicaments
NO116545B (fr)
DE1620442B2 (de) Verfahren zur Herstellung von 1-Acylindolverbindungen
NO128157B (fr)
EP0005154B1 (fr) Dérivés du 1-oxo-1H-pyrimido (6,1-b) benzothiazole, procédés pour leur préparation et compositions pharmaceutiques les contenant
Adams et al. 2-Aminopyridine 1-Oxides
CH631973A5 (de) Verfahren zur herstellung von benzimidazolderivaten.
DE2153600A1 (fr)
DK147197B (da) Analogifremgangsmaade til fremstilling af 2-hydrazonopropionsyrederivater
DE2438851C2 (de) N↑2↑-Dansyl-L-argininderivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
NO174928B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive enoletere av 6-klor-4-hydroksy-2-metyl-N-(2-pyridyl)-2H-tieno(2,3-e)-1,2-tiazin-3-karboksylsyreamid-1,1-dioksyd
US2966489A (en) G-nttro quinolone derivatives
NO133998B (fr)
DE2206890A1 (de) Substituierte Methoxyaminderivate, ihre Verwendung und Verfahren zur Herstellung von substituierten Methoxyaminderivaten
US3141017A (en) Acetals and ketals of 12alpha-dihydroxyprogesterone and 1-dehydro-12alpha, 17alpha-dihydroxyprogesterone
NO163557B (no) Kassettfilter.
EP0158312B1 (fr) Dérivés de la 1-cyclohéxyl-3,4-dihydroisoquinoléine, procédé pour leur préparation et médicament les contenant
AT299202B (de) Verfahren zur Herstellung von neuen substituierten Isochinolinen und von deren Säureadditionssalzen
US2602795A (en) Hydroxyalkyl alkyl derivatives of 5-nitroso-6-amino-1, 2, 3, 4-tetrahydro-2, 4-pyrimidinedione
DE2029991C3 (de) 2-Hydroxy-5-aminobenzamide, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
GB604563A (en) Improvements in and relating to the purification of penicillin salts
US3073838A (en) Derivatives of hydkogenateb pyridones
DE1620358C3 (de) Verfahren zur Herstellung von 1-Acyl-3-indolylcarbonsäure verbindungen